shares of Divis Laboratories moved up by 2.11 percent to Rs 6281.50 in early trade. At 09:50 am, the stock is trading among the top gainers on Nifty Next 50.
The company has demonstrated consistent financial performance. The consolidated revenue for the quarter-ending June 2025 stood at Rs 2,410 Crore, up from Rs 2,118 Crore in June 2024. Net profit for the same period was Rs 545 Crore, compared to Rs 430 Crore in the corresponding quarter of the previous year. Earnings per share (EPS) also increased to Rs 20.49 in June 2025 from Rs 16.20 in June 2024.
Here is a detailed look at the company's quarterly financial performance:
| Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 2,118.00 Crore | Rs 2,338.00 Crore | Rs 2,319.00 Crore | Rs 2,585.00 Crore | Rs 2,410.00 Crore |
| Net Profit | Rs 430.00 Crore | Rs 510.00 Crore | Rs 589.00 Crore | Rs 662.00 Crore | Rs 545.00 Crore |
| EPS | 16.20 | 19.20 | 22.20 | 24.93 | 20.49 |
The annual consolidated revenue for the year-ending March 2025 was Rs 9,360 Crore, a significant increase from Rs 7,845 Crore in the previous year. The net profit for the same period was Rs 2,191 Crore, up from Rs 1,600 Crore in the year-ending March 2024. The EPS also improved to Rs 82.53 in March 2025 from Rs 60.27 in March 2024.
Below is a summary of the company's yearly financials:
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 6,969.40 Crore | Rs 8,959.83 Crore | Rs 7,767.51 Crore | Rs 7,845.00 Crore | Rs 9,360.00 Crore |
| Net Profit | Rs 1,984.29 Crore | Rs 2,960.45 Crore | Rs 1,823.38 Crore | Rs 1,600.00 Crore | Rs 2,191.00 Crore |
| EPS | 74.75 | 111.52 | 68.69 | 60.27 | 82.53 |
| BVPS | 350.15 | 441.82 | 480.96 | 512.11 | 564.87 |
| ROE | 21.34 | 25.24 | 14.28 | 11.78 | 14.63 |
| Debt to Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
The company's financial ratios present the following data. The basic EPS was Rs 82.53 as of March 2025. The book value per share was Rs 564.87 as of March 2025. The debt to equity ratio was 0.00 as of March 2025.
Divis Laboratories announced a final dividend of Rs 30 per share on May 19, 2025, with an effective date of July 25, 2025. The company also announced a bonus issue on August 8, 2015, with an ex-bonus date of September 23, 2015, and a bonus ratio of 1:1.
Shares of Divis Laboratories moved up by 2.11 percent to Rs 6281.50 in early trade.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
